G Clagett

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Preventing Ischemic Stroke in Patients With Prior Stroke and Transient Ischemic Attack

Philip A. Wolf, G Clagett, J. Donald Easton et al. · Stroke · 1999 · 349 citations

Thrombosis, Transient Ischemic Attack, Cardiovascular Disease +12

Assessing risk associated with carotid endarterectomy. A statement for health professionals by an Ad Hoc Committee on Carotid Surgery Standards of the Stroke Council, American Heart Association.

Hugh G. Beebe, G Clagett, James A. DeWeese et al. · Circulation · 1989 · 122 citations

Endovascular Technique, Cerebrovascular Disease, Relative Risk +21

Platelet reactivity in vivo in dogs with arterial prostheses seeded with endothelial cells.

G Clagett, W. E. Burkel, John B. Sharefkin et al. · Circulation · 1984 · 51 citations · Full text

Endothelial Cells, Platelet Activity, Platelet Reactivity +23

Prevention of Venous Thromboembolism in General, Surgical Patients: Results of a Meta-Analysis

G Clagett, Joan Reisch · The Journal of Urology · 1989 · 39 citations

Urology1 Apr 1989Prevention, Surgery, Meta-analysis G.p +19